Skip to main content
Caplight Logo









Diametos

Diametos

Private
PotsdamHealthcare & Life Scienceshttps://diametos.com/

Last Round

Grant

Jul 5, 2021

Total Funding Raised

$2.62M

Company Overview

Diametos is a health care company that develops medical software solutions for analyzing the causes of snoring and assessing the risk of obstructive sleep apnea.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Telemedicine

Business Model

B2C

Customer Profile

Freemium, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

sleep apnea screeningsnoring analysisacoustic phenotypingmedical AIobstructive sleep apneasnoring appat-home sleep testAI diagnosticssleep techsoftware as a medical deviceSaMDdigital healthclinical decision supportB2B2C healthcarehealth insurance partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Diametos Comparables

Compare Diametos with similar companies based on industry and business-model similarity.

Diametos comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Apneal
88%
Pfizer
78%
Sleep.ai
70%

Diametos Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 5, 2021
SeedApr 13, 2021
GrantMar 2, 2021

Key People

Founding team and executive leadership

Christoph Janott

Chief Executive Officer

Executive Team

Diametos Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 19, 2026

    Grew 38% QoQ, from 13 to 18 employees.

  • Nov 10, 2024

    Monthly visitors grew 282% MoM, from 232 to 887.

Diametos Filings

Explore SEC and related filing metadata, where available.

Diametos filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Diametos's valuation, stock price, and market status.

Is Diametos a public or private company?

Diametos is a private company.

What is the current stock price of Diametos?

Diametos is a private company with no public stock price. No recent secondary market data is available.

How much is Diametos worth (valuation)?

Valuation information for Diametos is not publicly available.

Can I buy Diametos stock?

Diametos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Diametos's last funding round?

Diametos's most recent funding round was Grant on July 5, 2021.

Who are the main investors in Diametos?

Key investors in Diametos include Investitionsbank des Landes Brandenburg, Özbek Ventures GmbH, Antler AI Disrupt, Brandenburg Kapital, Business Buddies.

Will Diametos IPO soon?

No public IPO plans have been announced for Diametos.

How can I track Diametos secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Diametos's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPotsdam
Employee Range18
Year Founded2020
Last FundingJul 5, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?